Scarica l'app Stockscreener
3.14
1.26%
-0.04
Alumis Inc Borsa (ALMS) Ultime notizie
(ALMS) Trading Advice - news.stocktradersdaily.com
Guggenheim raises Alumis stock to buy with $18 price target By Investing.com - Investing.com Canada
Alumis (NASDAQ:ALMS) Coverage Initiated by Analysts at Guggenheim - Defense World
Alumis (ALMS) Projected to Post Quarterly Earnings on Wednesday - Defense World
Morgan Stanley Resumes Coverage of Alumis (ALMS) with $23 PT - MSN
Alumis resumed with a Buy at Guggenheim - TipRanks
Guggenheim raises Alumis stock to buy with $18 price target - Investing.com India
Traders Purchase High Volume of Put Options on Alumis (NASDAQ:ALMS) - Defense World
Alumis resumed with an Overweight at Morgan Stanley - TipRanks
Alumis to Present at the Jefferies Global Healthcare Investor Conference - The Manila Times
AyurMaya Capital Management's Strategic Acquisition in Alumis Inc - GuruFocus
Alumis CEO to Share Late-Stage Immune Disease Pipeline Updates at Jefferies Healthcare Conference - Stock Titan
News Flash: Analysts Just Made A Substantial Upgrade To Their Alumis Inc. (NASDAQ:ALMS) Forecasts - simplywall.st
Alumis completes enrollment of Phase 3 ONWARD program of ESK-001 - TipRanks
Alumis Inc. Completes Patient Enrollment for Phase 3 ONWARD Clinical Program Evaluating ESK-001 in Moderate-to-Severe Plaque Psoriasis - Nasdaq
Alumis Advances Game-Changing Oral Psoriasis Drug: 1,700 Patients Enrolled in Phase 3 Trial - Stock Titan
Largest borrow rate increases among liquid names - TipRanks
FY2026 Earnings Forecast for Alumis Issued By HC Wainwright - Defense World
Alumis completes merger with ACELYRIN, extends cash runway By Investing.com - Investing.com Canada
Alumis completes merger with ACELYRIN, extends cash runway - Investing.com Australia
Alumis Completes Merger With ACELYRIN, Strengthens Pipeline And Cash Runway - Nasdaq
Alumis, Acelyrin Close Merger - marketscreener.com
Alumis Inc. Completes Merger with ACELYRIN, Inc. - TipRanks
ACELYRIN Completes Merger and Delists from Nasdaq - TipRanks
Alumis Inc. Completes Merger with ACELYRIN, Inc. to Strengthen Pipeline in Immune-Mediated Disease Therapies - Nasdaq
Alumis completes merger with Acelyrin - TipRanks
Alumis Completes Merger with ACELYRIN - TradingView
Alumis-ACELYRIN Merger Creates Powerhouse in Immune Disease Drug Development with 2027 Cash Runway - Stock Titan
ACELYRIN Stockholders Approve Merger with Alumis - TipRanks
Alumis Inc. Stockholders Approve Merger with ACELYRIN - TipRanks
How To Trade (ALMS) - news.stocktradersdaily.com
Alumis Inc. Reports Q1 2025 Financial Results and Strategic Progress - TipRanks
Oppenheimer Trims Price Target on Alumis to $25 From $26, Keeps Outperform Rating - marketscreener.com
Alumis Reports First Quarter 2025 Financial Results and Highlights Recent Achievements - The Manila Times
Alumis Inc. Reports First Quarter 2025 Financial Results - TradingView
Earnings Flash (ALMS) ALUMIS INC. Reports Q1 Revenue $17.4M - marketscreener.com
ACELYRIN Stockholders Approve Merger with Alumis to Create Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases - The Manila Times
How a Peninsula biotech's merger drama overcame several investor headaches - The Business Journals
ACELYRIN shareholders approve Alumis merger deal By Investing.com - Investing.com India
Alumis wins shareholder nod for ACELYRIN merger By Investing.com - Investing.com India
Alumis, Acelyrin Shareholders Approve Merger Deal - marketscreener.com
Alumis Stockholders Approve Merger with ACELYRIN - The Manila Times
Alumis wins shareholder nod for ACELYRIN merger - Investing.com
ACELYRIN shareholders approve Alumis merger deal - Investing.com
Alumis Inc. Stockholders Approve Merger with ACELYRIN, INC. - Nasdaq
Alumis Stockholders Approve Merger With Acelyrin - marketscreener.com
Acelyrin (SLRN) Stockholders Approve Merger with Alumis (ALMS) - StreetInsider
ACELYRIN-Alumis Merger Gets Green Light: New Powerhouse in Immune Disease Treatment Emerges - Stock Titan
Barclays PLC Has $193,000 Stock Holdings in Alumis Inc. (NASDAQ:ALMS) - Defense World
Mariner LLC Buys Shares of 18,122 Alumis Inc. (NASDAQ:ALMS) - Defense World
(ALMS) On The My Stocks Page - news.stocktradersdaily.com
1.91%
1.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):